Finally, wild type FOXD2-AS1 promoter was cloned into the pGL3 vector and subsequently co-transfected with E2F1 siRNAs and negative control siRNA into bladder cancer cells. This evidence concerns the gene FOXD2 and urinary bladder cancer.